Testing demonstrates an automated semi-continuous process strategy for viral inactivation with steps that mimic batch processing.
Perfusion processes can attractive for biologics drug manufacturing; however, obstacles remain.
Continuous processing of 100 g of monoclonal antibody in 24 hours has been demonstrated using lab-scale equipment.